GENETIC LOCI RESPONSIBLE FOR GROWTH RESTRICTION OF MOUSE-ADAPTED DENGUE VIRUSES

负责小鼠适应登革热病毒生长限制的基因位点

基本信息

项目摘要

Serial intracerebral passage of dengue type 1 or type 2 virus in mice was shown previously to select for mouse neurovirulent mutants which also proved to be attenuated for humans. In a similar manner a neurovirulent mutant of DEN4 (strain H241) was selected by serial intracerebral passage in mice. DEN4 H241 neurovirulent (N) replicated less efficiently than its DEN4 H241 parent (P) in simian LLC-MK2 cells. An intratypic DEN4 chimera containing the C-PreM-E structural protein genes from DEN4 H241N also exhibited marked restriction of growth in LLC-MK2 cells. Analysis of virion proteins of DEN4 H241N or its derived C-PreM-E chimera grown in mosquito C6/36 cells indicated that very little M was produced. There is considerable evidence that immature PreM-containing flavivirus virions are less infectious than the mature M-containing virus. For this reason, we constructed a panel of chimeras that contained one or more of the variant amino acids of the mutant C-PreM-E sequence substituting for the corresponding sequence of the parental virus. These chimeras were analyzed to determine if any of these mutations was responsible for inefficient PreM cleavage. Mutants which contained two substitutions in PreM, i. e., Lys165-Glu and Val188-Ala, with or without the Thr81-Ile substitution in C, exhibited reduced PreM cleavage. Reduction of PreM cleavage was also observed for chimeras which contain multiple mutations in E, i.e., Thr434-Ile, Ser435-Pro, and Phe680-Leu, with the exception of the chimera containing Thr434-Ile and Ser435-Pro. Efficient PreM cleavage was required for virus to achieve high level of replication in simian LLC-MK2 cells. Similarly, the genetic basis for the reduced replicative efficiency of the mouse-passaged MD-1 vaccine strain in LLC-MK2 cells compared to its parental DEN1 Hawaii strain was investigated. A combination of three substitutions in E independently caused restriction of replication in simian cells. A single Val207-Ala substitution in PreM was also independently responsible for restriction of replication of MD-1 or its derived chimera in LLC-MK2 cells. This PreM mutation is located immediately downstream of the N-terminus of M, which is cleaved from PreM by the host cell furin enzyme. The Val207-Ala mutation did not affect PreM cleavage in mosquito cells, but this mutation might possibly restrict PreM cleavage in simian cells and thus, be responsible for growth restriction.
登革热 1 型或 2 型病毒在小鼠脑内连续传代 先前显示用于选择小鼠神经毒性突变体,该突变体也 已被证明对人类有减弱作用。 以类似的方式,神经毒力 通过连续脑内传代选择 DEN4 突变体(H241 株) 在小鼠中。 DEN4 H241 神经毒力 (N) 的复制效率低于 其 DEN4 H241 亲本 (P) 在猿猴 LLC-MK2 细胞中。 型内 DEN4 含有来自 DEN4 H241N 的 C-PreM-E 结构蛋白基因的嵌合体 LLC-MK2 细胞的生长也表现出明显的限制。 分析 DEN4 H241N 或其衍生的 C-PreM-E 嵌合体的病毒体蛋白的数量 在蚊子 C6/36 细胞中,表明产生的 M 非常少。那里 大量证据表明,未成熟的含有 PreM 的黄病毒颗粒 与成熟的含 M 病毒相比,其传染性较低。 为此原因, 我们构建了一组嵌合体,其中包含一个或多个 突变体C-PreM-E序列的变体氨基酸取代 亲代病毒的相应序列。 这些嵌合体是 分析以确定是否有任何这些突变导致 PreM 裂解效率低下。 含有两个取代的突变体 PreM,i。例如,Lys165-Glu 和 Val188-Ala,有或没有 Thr81-Ile C 中的取代,表现出 PreM 裂解减少。 减少PreM 还观察到包含多个突变的嵌合体的裂解 在 E 中,即 Thr434-Ile、Ser435-Pro 和 Phe680-Leu,但例外 含有 Thr434-Ile 和 Ser435-Pro 的嵌合体。 高效学前班 病毒需要进行切割才能实现高水平的复制 猿猴 LLC-MK2 细胞。 同样,减少的遗传基础 小鼠传代 MD-1 疫苗株的复制效率 LLC-MK2 细胞与其亲本 DEN1 Hawaii 株相比 调查了。 E 中三个独立取代的组合 导致猿猴细胞的复制受到限制。 单个 Val207-Ala PreM 中的替代也独立地负责限制 MD-1 或​​其衍生嵌合体在 LLC-MK2 细胞中的复制。 这 PreM 突变位于 M N 末端的紧下游, 它被宿主细胞弗林蛋白酶从 PreM 上切割下来。 Val207-丙氨酸 突变并不影响蚊子细胞中的 PreM 裂解,但这 突变可能会限制猿猴细胞中的 PreM 裂解,因此, 负责生长限制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

C J LAI其他文献

C J LAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('C J LAI', 18)}}的其他基金

PROCESSING AND IMMUNOGENICITY OF DENGUE TYPE 4 VIRUS NONSTRUCTURAL PROTEIN NS1
登革热 4 型病毒非结构蛋白 NS1 的加工和免疫原性
  • 批准号:
    3790778
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
FUNCTIONAL ANALYSIS OF SIGNAL SEQUENCES OF INFLUENZA VIRUS HEMAGGLUTININ
流感病毒血凝素信号序列的功能分析
  • 批准号:
    4688500
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR BIOLOGY OF DENGUE AND OTHER FLAVIVIRUSES
登革热和其他黄病毒的分子生物学
  • 批准号:
    6160656
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
FUNCTIONAL ANALYSIS OF DENGUE NONSTRUCTURAL PROTEINS, NS2B AND NS3
登革热非结构蛋白 NS2B 和 NS3 的功能分析
  • 批准号:
    3790793
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC LOCI RESPONSIBLE FOR GROWTH RESTRICTION OF MOUSE-ADAPTED DENGUE VIRUSES
负责小鼠适应登革热病毒生长限制的基因位点
  • 批准号:
    5200590
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC LOCI RESPONSIBLE FOR GROWTH RESTRICTION OF MOUSE-ADAPTED DENGUE VIRUSES
负责小鼠适应登革热病毒生长限制的基因位点
  • 批准号:
    3746679
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
THE COMPLETE NUCLEOTIDE SEQUENCE OF DENGUE TYPE 4 VIRUS
登革热 4 型病毒的完整核苷酸序列
  • 批准号:
    3818250
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PROCESSING OF DENGUE VIRUS POLYPROTEIN NS3-NS4A-NS4B-NS5 DOMAIN
登革热病毒多蛋白NS3-NS4A-NS4B-NS5结构域的加工
  • 批准号:
    3790819
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC VARIATION AMONG DENGUE VIRUSES
登革热病毒之间的基因变异
  • 批准号:
    4688567
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DEN4 DELETION MUTANTS AS VACCINES & VIRUSES OF OTHER SEROTYPES AS DENGUE VACCINE
DEN4 缺失突变体作为疫苗
  • 批准号:
    6160695
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
  • 批准号:
    22KJ2450
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
  • 批准号:
    23H03151
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    23K08067
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
  • 批准号:
    22K19629
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
  • 批准号:
    22K09763
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
  • 批准号:
    20K17570
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
  • 批准号:
    20K16311
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
  • 批准号:
    20K08953
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
  • 批准号:
    20H03771
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了